Cite
HARVARD Citation
Babak, M. et al. (2021). Interfering with Metabolic Profile of Triple‐Negative Breast Cancers Using Rationally Designed Metformin Prodrugs. Angewandte Chemie. pp. 13517-13525. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Babak, M. et al. (2021). Interfering with Metabolic Profile of Triple‐Negative Breast Cancers Using Rationally Designed Metformin Prodrugs. Angewandte Chemie. pp. 13517-13525. [Online].